awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33167422-4A4444A4-CFE5-4D69-BBAD-164FF5DC21CC
Q33167422-4A4444A4-CFE5-4D69-BBAD-164FF5DC21CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33167422-4A4444A4-CFE5-4D69-BBAD-164FF5DC21CC
A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia.
P2860
Q33167422-4A4444A4-CFE5-4D69-BBAD-164FF5DC21CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33167422-4A4444A4-CFE5-4D69-BBAD-164FF5DC21CC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
69102a9f4e1da72831f69f6f003d1553ddf6bf47
P2860
Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemia